Vorinostat (SAHA) Mechanism of Action: HDAC Inhibition in Tumor Cell Research

Vorinostat (SAHA) MOA:Targeting HDAC/Apoptosis Pathway for Oncology Research

🎯 check Vorinostat (SAHA) product page

Vorinostat is a potent, reversible pan-HDAC inhibitor. It affects Akt/mTOR signaling by chelating zinc, promoting apoptosis.

Primary Applications and Mechanism of Action